Non-small Cell Lung Cancer

Learn about ALK-positive NSCLC, how targeted therapy works, and the sequence of ALK inhibitors used to manage this lung cancer subtype effectively.

Unlock personalized care by decoding your NSCLC pathology report. Learn how subtypes, EGFR, and PD-L1 levels guide your lung cancer treatment and survival path.

New research presented in Boston at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting highlights two approaches that could help personalize radiation treatment for people with non-small cell lung cancer (NSCLC). The findings looked at radiation therapy for older and frail adults with stage II–III NSCLC and the long-term benefits of combining radiation […]

Managing lung cancer costs? Discover essential financial assistance, copay programs, and grants to help navigate financial toxicity and stay on your treatment.

Facing a cancer treatment denial? Learn how to fight insurance denials, write a successful appeal letter, and navigate the process to get the care you need.